Skip to content

Insider · CIK 0001422995

Cappel Markus J.

Reports to the SEC for 1 company · MOUNTAIN VIEW, CA

Transactions

50

Companies

1

Filings

4

CIK

0001422995

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2022-10-20ChemoCentryx, Inc.Stock OptionD Disposition to Issuer—
2022-10-20ChemoCentryx, Inc.Restricted Stock UnitD Disposition to Issuer—
2022-10-20ChemoCentryx, Inc.Stock OptionD Disposition to Issuer—
2022-10-20ChemoCentryx, Inc.Stock OptionD Disposition to Issuer—
2022-10-20ChemoCentryx, Inc.D Disposition to Issuer—
2022-10-20ChemoCentryx, Inc.Stock OptionD Disposition to Issuer—
2022-10-20ChemoCentryx, Inc.Stock OptionD Disposition to Issuer—
2022-10-20ChemoCentryx, Inc.Stock OptionD Disposition to Issuer—
2022-10-20ChemoCentryx, Inc.Stock OptionD Disposition to Issuer—
2022-10-20ChemoCentryx, Inc.Stock OptionD Disposition to Issuer—
2022-10-20ChemoCentryx, Inc.Stock OptionD Disposition to Issuer—
2022-10-20ChemoCentryx, Inc.Stock OptionD Disposition to Issuer—
2022-10-20ChemoCentryx, Inc.Stock OptionD Disposition to Issuer—
2022-08-04ChemoCentryx, Inc.S Sale−$380K
2022-02-22ChemoCentryx, Inc.Restricted Stock UnitsA Award—
2022-02-22ChemoCentryx, Inc.Stock Option (right to buy)A Award—
2022-01-01ChemoCentryx, Inc.M Exercise/Conversion—
2022-01-01ChemoCentryx, Inc.Restricted Stock UnitsM Exercise/Conversion—
2022-01-01ChemoCentryx, Inc.M Exercise/Conversion—
2022-01-01ChemoCentryx, Inc.Restricted Stock UnitsM Exercise/Conversion—
2022-01-01ChemoCentryx, Inc.Restricted Stock UnitsM Exercise/Conversion—
2022-01-01ChemoCentryx, Inc.F Tax Payment−$420K
2022-01-01ChemoCentryx, Inc.M Exercise/Conversion—
2021-03-01ChemoCentryx, Inc.Stock Option (right to buy)M Exercise/Conversion—
2021-03-01ChemoCentryx, Inc.Stock Option (right to buy)M Exercise/Conversion—
2021-03-01ChemoCentryx, Inc.Stock Option (right to buy)M Exercise/Conversion—
2021-03-01ChemoCentryx, Inc.S Sale−$370K
2021-03-01ChemoCentryx, Inc.S Sale−$1.42M
2021-03-01ChemoCentryx, Inc.S Sale−$477K
2021-03-01ChemoCentryx, Inc.M Exercise/Conversion+$176K
2021-03-01ChemoCentryx, Inc.M Exercise/Conversion+$127K
2021-03-01ChemoCentryx, Inc.M Exercise/Conversion+$35.9K
2021-02-25ChemoCentryx, Inc.Stock Option (right to buy)A Award—
2021-02-25ChemoCentryx, Inc.Restricted Stock UnitsA Award—
2021-02-09ChemoCentryx, Inc.S Sale−$48.8K
2021-02-09ChemoCentryx, Inc.Stock Option (right to buy)M Exercise/Conversion—
2021-02-09ChemoCentryx, Inc.M Exercise/Conversion+$7,714
2021-02-08ChemoCentryx, Inc.Stock Option (right to buy)M Exercise/Conversion—
2021-02-08ChemoCentryx, Inc.S Sale−$13.6K
2021-02-08ChemoCentryx, Inc.S Sale−$486K
2021-02-08ChemoCentryx, Inc.M Exercise/Conversion+$81.8K
2021-02-05ChemoCentryx, Inc.Stock Option (right to buy)M Exercise/Conversion—
2021-02-05ChemoCentryx, Inc.M Exercise/Conversion+$8,871.1
2021-02-05ChemoCentryx, Inc.S Sale−$54K
2021-02-04ChemoCentryx, Inc.Stock Option (right to buy)M Exercise/Conversion—
2021-02-04ChemoCentryx, Inc.S Sale−$94K
2021-02-04ChemoCentryx, Inc.M Exercise/Conversion+$15.4K
2021-01-25ChemoCentryx, Inc.Stock Option (right to buy)M Exercise/Conversion—
2021-01-25ChemoCentryx, Inc.S Sale−$92.2K
2021-01-25ChemoCentryx, Inc.M Exercise/Conversion+$15.2K

Recent filings

4

Companies

1

Address

C/O CHEMOCENTRYX, INC. 850 MAUDE AVENUE

MOUNTAIN VIEW, CA, 94043